Zhejiang Jiaoke: the amount of newly signed orders in the first quarter was 9.488 billion yuan, and the order stock was sufficient

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Unpacking China | Key Chinese Firms to Watch This Week （31/05/2026-06/06/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

WeRide (文远知行) Partners with Uber to Launch Robotaxi Service in Madrid, Marking First Joint Entry into European Market

WeRide (文远知行) has partnered with Uber to launch a commercial Robotaxi pilot in Madrid within the year—marking their first joint entry into Europe—via an asset-light model where WeRide provides the technology and AVOMO manages the fleet.

Xiaomi EV (小米汽车) Anticipates Official Global Launch in the Second Half of 2027

Xiaomi EV (小米汽车) plans to officially launch its overseas expansion in the second half of 2027, adopting an unconventional strategy that targets developed, right-hand drive, and mid-to-high-end markets first to directly challenge global luxury auto giants.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?